Delivery Order SPE2DB22D2211-SPE2DB24FNCE6
- Not listed
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a global pharmaceutical sourcing and distribution services company. The $6,903.75 order is for the delivery of Ondansetron ODT 4 mg tablets to support military treatment programs and facilities. AmerisourceBergen Drug Corp also holds an Indefinite Delivery Contract (IDC) with DLA valued up to $999,999,999.00 through December...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $15,778.71 order is for the supply of 4564042267 Ondansetron ODT 4 MG Tablet 30s, a prescription medication. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the...
- This firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical was awarded to Amerisourcebergen Drug Corp, a subsidiary of the for-profit pharmaceutical distribution company Amerisourcebergen Corporation. The $3,139.70 contract is for the provision of Ondansetron ODT 4 mg tablets to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) from DLA, valued up to $999,999,999.00 through...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $7,077.84 award is for the delivery of 4563830264, which is described as ondansetron ODT 8 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $5,448.45 award is for the supply of Ondansetron ODT 4 mg tablets to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $5,373.53 award is for the supply of 4,563,943,906 units of Ondansetron ODT 8 mg tablets. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide pharmaceutical...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The award, valued at $2,464.20, is for the delivery of Ondansetron ODT 4 mg tablets to support military treatment programs and facilities. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical...
- This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,935.24, is for the delivery of Ondansetron HCL 8 mg tablets over a period ending on April 18, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of pharmaceutical products and medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,707.55 firm fixed price delivery order is for the supply of 4,566,197,426 units of Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of October 25, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,668.97 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that serves as the primary vehicle for Amerisourcebergen to provide pharmaceutical products and medical supplies to support the Department of...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB24FNCE6Delivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $2,202.00 award is for the delivery of Ondansetron ODT 4 mg tablets to support military medical treatment programs and facilities. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to provide pharmaceutical products and medical supplies to DLA Troop Support Medical. This specific delivery order does not have a set-aside designation. Amerisourcebergen Drug Corp is also the prime contractor on a contract with the Department of Justice Federal Bureau of Investigation to provide medical supplies and prescription medications, valued up to $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 3/29/24 |